The Extracorporeal Membrane Oxygenation Market focuses on life-support systems that provide prolonged cardiac and respiratory support to patients with severe heart or lung failure. ECMO is increasingly used in critical care settings for patients unresponsive to conventional therapies. In 2025, the global extracorporeal membrane oxygenation market was valued at USD 253.27 Million and is expected to reach USD 404.76 Million by 2035, growing at a CAGR of 4.80% from 2026 to 2035.

How Big Is the Extracorporeal Membrane Oxygenation Market and What Drives Growth?

Market growth is driven by the rising incidence of acute respiratory distress syndrome (ARDS), cardiac failure, and post-surgical complications. Increased adoption of ECMO during complex cardiac surgeries and emergency situations such as extracorporeal cardiopulmonary resuscitation (ECPR) is also fueling demand. Continuous technological improvements in oxygenators and pumps are making ECMO safer and more efficient.

What Are the Key Components and Modalities in the ECMO Market?

By component, oxygenators and pumps hold a significant market share due to their critical role in blood oxygenation and circulation. Cannulas, controllers, and accessories further support system functionality. Based on modality, veno-venous (VV) ECMO dominates for respiratory support, while veno-arterial (VA) ECMO is widely used for cardiac failure. Arterio-venous ECMO serves niche applications.

Request sample report Explore

Which Patient Types and Applications Drive Market Demand?

Neonates represent a major patient group due to high survival benefits in neonatal respiratory failure, followed by pediatric and adult patients. Application-wise, respiratory support accounts for the largest share, while cardiac support and ECPR are gaining momentum in emergency and trauma care settings.

Which Regions and Companies Lead the Extracorporeal Membrane Oxygenation Market?

North America leads the market due to advanced ICU infrastructure and high adoption of life-support technologies. Europe follows closely, while Asia Pacific is emerging as a high-growth region due to expanding critical care capabilities. Key companies include Medtronic PLC, Getinge AB, LivaNova PLC, Terumo Corporation, and EUROSETS S.R.L, focusing on innovation and system integration.